John C Martin

John C Martin has an estimated net worth of $1.23 Billion. This is based on reported shares across multiple companies, which include Sarepta Therapeutics, Inc., Kronos Bio, Inc., GILEAD SCIENCES INC, and GEN PROBE INC.

2007 was John C Martin's most active year for acquiring shares with 21 total transactions. John C Martin's most active month to acquire stocks was the month of January. 2007 was John C Martin's most active year for disposing of shares, totalling 102 transactions. John C Martin's most active month to dispose stocks was the month of October. 2015 saw John C Martin paying a total of $26,125,731.78 for 2,346,914 shares, this is the most they've acquired in one year. In 2015 John C Martin cashed out on 4,110,631 shares for a total of $215,978,097.45, their largest year based on trade value.